Guidance

Influenza vaccine: ovalbumin content

Data on the ovalbumin content of the influenza vaccines for the 2021 to 2022 flu season.

• From: Public Health England
• Published: 29 July 2016
• Last updated: 23 June 2021
  Show all updates

  1. 23 June 2021

     Updated Quadrivalent Influvac® sub-unit Tetra to suitable for children from 6 months of age.

  2. 14 May 2021

     Updated ovalbumin content for the 2021 to 2022 flu season.

  3. 1 December 2020

     Ovalbumin content list updated.

  4. 10 June 2020

     Added table for the 2020 to 2021 flu season.

  5. 4 July 2019

     Updated title of document to 'Influenza vaccines: 2019 to 2020 flu season.'

  6. 3 July 2019

     Updated with the vaccines for the 2018 to 2019 flu season.

  7. 11 January 2019

     Added a note to the table about an approved batch of Vaxigrip Tetra and updated the age indication for Mylan’s quadrivalent influenza vaccine products to 3 years and over, instead of from 18.

  8. 9 August 2018

     Added this season's Ovalbumin influenza vaccine table.

  9. 2 August 2017

     Added Ovalbumin content of the influenza vaccines for 2017 to 2018 flu season.

  10. 29 July 2016

      First published.

This publication was withdrawn on 4 April 2022

This guidance was for the 2021 to 2022 flu season. Please see the latest list of vaccines marketed in the UK.

Documents

[Withdrawn] Influenza vaccines: 2021 to 2022 flu season

HTML

[Withdrawn] Influenza vaccines: 2021 to 2022 flu season (print version)

Ref: PHE publications gateway number 2021199

PDF, 739 KB, 1 page

Details

This table lists all of the ovalbumin content of the influenza vaccines that are marketed in the UK for the 2021 to 2022 flu vaccination season.

For information on the use of influenza vaccines in egg allergic individuals please see the green book influenza chapter.